Mission: Contribute to securing the country's needs of human vaccines and biotechnological medicines by raising the efficiency of local production.
Vision: Achieve leadership in production, development and marketing of biological preparations, sera, and human vaccines for local and regional markets.
Sites: Agouza HQ (61K m²), Helwan Farm (95K m²), 6th of October Industrial Complex (62K m²).
Facilities: B#60 Lyo & liquid sterile filling (Covid-19, Penta, DTP, DT, Hep B, TT); B#1 liquid sterile filling (Antisera); B#2 Biotechnology plant (Insulin, Rabies); BCG-T Facility; Antigen bulk production (DP block, TT block).
Quality: ISO 9001, ISO 14001, ISO 45001, WHO/GMP compliant. Hosts WHO Polio Regional Reference Lab and WHO National Influenza Centre.
Technology Transfer agreements with SINOVAC, Serum Institute, GSK, Sanofi, Green Cross, RIVM, CDBIO, Walvex.
Exports to: Algeria, Benin, Cyprus, Ethiopia, Eritrea, Iraq, Lebanon, Libya, Niger, North Korea, Palestine, Sudan, Yemen.